Saffron crocin increases plasma oxygen release by 80%

The claim that saffron crocin increases plasma oxygen release by 80% is not supported as written. It appears to mix up crocin with crocetin and an experimental crocetin-derived compound studied for oxygen diffusion. That research does not show that eating saffron or drinking saffron tea raises a person’s blood oxygen by 80%.

The original report attributed the statement to Mohsen Pouyan, introduced as a medicinal-plant expert in South Khorasan. It also described saffron’s compounds and repeated several traditional health uses. This review retains that historical account while separating it from what human research can currently establish.

What the 80% oxygen claim gets wrong

Three different terms sit behind the confusion:

• Crocin is the name used for a family of water-soluble carotenoid pigments that give saffron its colour.
• Crocetin is the smaller carotenoid structure linked to those sugars. After oral crocins are digested, crocetin—not intact crocin—is the main related compound detected in human plasma.
• Trans-sodium crocetinate (TSC) is a water-soluble salt derived from crocetin and investigated as an experimental drug. It is not the same as culinary saffron, saffron tea or crocin from saffron.

A physical-chemistry study of TSC reported roughly a 25–30% increase in the diffusion coefficient of oxygen through water under its experimental conditions. A later laboratory comparison of injectable oxygenation agents also tested TSC in a controlled in-vitro circulation model. Neither paper says that crocin releases 80% more oxygen from human plasma after saffron is eaten.

“Diffusion” and “release” are not synonyms here. Diffusion describes how molecules move through a medium; blood-oxygen saturation is a clinical measurement. The old headline combines the wrong compound, outcome and percentage, so it should not be read as medical advice or a result a consumer can expect.

How crocin from saffron is processed

Research into crocin saffron chemistry has to account for digestion. A pharmacokinetic review concluded that orally administered crocin is converted in the intestine and that crocetin appears in plasma at low concentrations. A small human pharmacokinetic study of 13 volunteers likewise found that crocin isomers from a standardised extract were transformed into crocetin, which was detected in plasma after 60–90 minutes. The study helps explain metabolism; it did not test whether saffron improves blood oxygen.

This distinction matters whenever a laboratory result is translated into a food claim. An isolated or chemically modified compound, delivered at a defined concentration in water, plasma or by injection, cannot automatically tell us what a culinary amount of saffron does in the body.

The compounds behind saffron’s colour, taste and aroma

Pouyan’s account associated the stigma with a volatile essential oil, picrocrocin, crocin and crocetin. Modern descriptions are more precise: crocins supply much of saffron’s red-gold colour, picrocrocin contributes bitterness, and the volatile compound safranal is central to its aroma. Crocetin is the carotenoid core related to crocins.

Saffron comes from the dried stigmas of Crocus sativus, a perennial plant in the iris family, Iridaceae. South Khorasan is one of Iran’s important growing regions, and Qaenat—also rendered Ghainat in the archived report—has long been associated with regional saffron production. Those agricultural facts do not validate a clinical claim, but they preserve the setting in which the original remarks were made.

What does the health evidence actually show?

Saffron research covers numerous preparations, doses and conditions. A broad review of 19 systematic reviews and meta-analyses found encouraging signals in several areas but also substantial heterogeneity and a need for stronger methodology. A result for one standardised extract and one defined outcome should not be generalised to every saffron product or illness.

Asthma

The old article called saffron sedative and listed asthma among its uses. One randomised trial involving 80 adults with mild or moderate allergic asthma studied 100 mg per day of saffron for eight weeks and reported improvement in some symptom measures. It was a single, short trial; the between-group result for asthma severity did not reach conventional statistical significance, and it does not establish saffron as a substitute for an inhaler or an asthma action plan. A 2024 meta-analysis of animal studies explicitly called for more human trials.

Pertussis and mucosal inflammation

The historical account also named pertussis (whooping cough) and inflammation of mucous membranes. We found no reliable clinical evidence supporting saffron as a treatment for either. Pertussis can be serious and contagious, especially for infants; suspected infection needs prompt medical assessment rather than a spice-based remedy. “Mucosal inflammation” is too broad to support one treatment claim because its cause and affected tissue must first be identified.

Sleep, headache and the senses

The archived text described saffron as refreshing, said it strengthens the senses and brain, and called inhaling saffron hypnotic. It also advised rubbing it on the forehead to relieve headaches and eliminate insomnia. These are traditional or promotional assertions, not established instructions. Evidence from an oral standardised extract cannot validate inhaling saffron powder or applying it to the forehead, and “eliminates insomnia” is much stronger than the evidence permits.

Persistent insomnia, a new severe headache, breathing difficulty or a low oxygen reading deserves appropriate medical assessment. Saffron should not delay urgent care or replace prescribed treatment.

Why the old two-gram brew is not a verified treatment

The earlier version instructed readers to brew 2 grams of saffron in one litre of boiling water for half an hour and drink it during the day. That is a concentrated preparation, and the article supplied no clinical source, product standard or individual safety assessment for it. It should therefore not be adopted as a treatment recipe.

Food use and concentrated use are different exposures. Pregnancy, medicines, allergies and medical conditions can change what is appropriate. Anyone considering a saffron extract or concentrated preparation for a health purpose should discuss the exact product and amount with a qualified clinician or pharmacist.

A more accurate conclusion

Saffron contains crocins, and digestion can produce crocetin. Researchers have separately studied crocetin-derived compounds for their effects on molecular diffusion. That chain of facts is scientifically interesting, but it does not support the claim that saffron crocin increases plasma oxygen release by 80%.

The responsible interpretation is narrower: keep crocin, crocetin and TSC distinct; distinguish a laboratory diffusion measurement from a person’s oxygen level; and judge each health claim by the preparation and human outcome that were actually tested.